These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22925213)

  • 1. Current problems of in vivo developmental neurotoxicity tests and a new in vivo approach focusing on each step of the developing central nervous system.
    Kuwagata M
    Congenit Anom (Kyoto); 2012 Sep; 52(3):129-39. PubMed ID: 22925213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural stem cells for developmental neurotoxicity studies.
    Tofighi R; Moors M; Bose R; Ibrahim WN; Ceccatelli S
    Methods Mol Biol; 2011; 758():67-80. PubMed ID: 21815059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNT-EST: a predictive embryonic stem cell-based assay for developmental neurotoxicity testing in vitro.
    Hayess K; Riebeling C; Pirow R; Steinfath M; Sittner D; Slawik B; Luch A; Seiler AE
    Toxicology; 2013 Dec; 314(1):135-47. PubMed ID: 24096155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints.
    Bal-Price AK; Hogberg HT; Buzanska L; Lenas P; van Vliet E; Hartung T
    Neurotoxicology; 2010 Sep; 31(5):545-54. PubMed ID: 19969020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Don't judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing.
    de Groot MW; Westerink RH; Dingemans MM
    Toxicol Sci; 2013 Mar; 132(1):1-7. PubMed ID: 22961093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 'best practices' approach to neuropathologic assessment in developmental neurotoxicity testing--for today.
    Bolon B; Garman R; Jensen K; Krinke G; Stuart B;
    Toxicol Pathol; 2006; 34(3):296-313. PubMed ID: 16698729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental neuropathology in DNT-studies--a sensitive tool for the detection and characterization of developmental neurotoxicants.
    Kaufmann W; Gröters S
    Reprod Toxicol; 2006 Aug; 22(2):196-213. PubMed ID: 16781841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An industry perspective: A streamlined screening strategy using alternative models for chemical assessment of developmental neurotoxicity.
    Li J; Settivari R; LeBaron MJ; Marty MS
    Neurotoxicology; 2019 Jul; 73():17-30. PubMed ID: 30786249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurospheres as a model for developmental neurotoxicity testing.
    Fritsche E; Gassmann K; Schreiber T
    Methods Mol Biol; 2011; 758():99-114. PubMed ID: 21815061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
    Hass U
    Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
    Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
    Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview on Human Umbilical Cord Blood Stem Cell-Based Alternative In Vitro Models for Developmental Neurotoxicity Assessment.
    Singh AK; Kashyap MP
    Mol Neurobiol; 2016 Jul; 53(5):3216-3226. PubMed ID: 26041658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole genome microarray analysis of neural progenitor C17.2 cells during differentiation and validation of 30 neural mRNA biomarkers for estimation of developmental neurotoxicity.
    Attoff K; Gliga A; Lundqvist J; Norinder U; Forsby A
    PLoS One; 2017; 12(12):e0190066. PubMed ID: 29261810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach.
    Hogberg HT; Kinsner-Ovaskainen A; Coecke S; Hartung T; Bal-Price AK
    Toxicol Sci; 2010 Jan; 113(1):95-115. PubMed ID: 19651682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and other alternative approaches to developmental neurotoxicity testing (DNT).
    Lein P; Silbergeld E; Locke P; Goldberg AM
    Environ Toxicol Pharmacol; 2005 May; 19(3):735-44. PubMed ID: 21783550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative human and rat neurospheres reveal species differences in chemical effects on neurodevelopmental key events.
    Baumann J; Gassmann K; Masjosthusmann S; DeBoer D; Bendt F; Giersiefer S; Fritsche E
    Arch Toxicol; 2016 Jun; 90(6):1415-27. PubMed ID: 26216354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M; Willett C; Pistollato F; Bal-Price A
    Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of a human stem cell line to identify risk of developmental neurotoxicity with antiepileptic drugs.
    Cao WS; Livesey JC; Halliwell RF
    Toxicol In Vitro; 2015 Apr; 29(3):592-9. PubMed ID: 25637331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.